Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaaki Shiohara is active.

Publication


Featured researches published by Masaaki Shiohara.


Cancer | 1998

Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas

Rossella Elisei; Masaaki Shiohara; H. Phillip Koeffler; James A. Fagin

D‐type cyclins, in association with the cyclin‐dependent kinases CDK4 and CDK6, promote progression through the G1 phase of the cell cycle. CDK activity is modulated by inhibitors such as p15INK4b and p16INK4a. Loss of function of p15INK4b and p16INK4a (multiple tumor suppressor‐I and CDK4 inhibitor) determines impairment in the control of the cell cycle and contributes to the transformation of several cell types.


Leukemia Research | 1995

Expression of Id2 and Id3 mRNA in human lymphocytes

Akira Ishiguro; Konstantin Spirin; Masaaki Shiohara; Andreas Tobler; John D. Norton; Muriel Rigolet; Toshikazu Shimbo; H. Phillip Koeffler

Helix-loop-helix (HLH) transcription factors are involved in cellular growth and differentiation. The Id (inhibitor of DNA binding and differentiation) HLH proteins, in a dominantly negative fashion, regulate transcriptional activities of basic HLH proteins. We examined by northern hybridization the expression of Id2 and Id3 mRNA in human leukemia/lymphoma lines and patient samples, as well as resting and activated normal human lymphocytes from peripheral blood (PBL). The Id2 mRNA was abundantly expressed in 5/12 T-cell and 3/4 B-cell lines, and Id3 mRNA was detected in 4/12 T-cell and 3/4 B-cell lines. Interestingly, Id2, but not Id3, mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I (HTLV-I) (ATL-1k, MT-2, S-LB1) and type II (Mo). Another unexpected finding was that T-cell leukemias and T-cell lines often expressed either Id2 or Id3 mRNA. In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA, but not Id3 mRNA. Upon PHA-stimulation, Id2 expression decreased and Id3 levels increased with biphasic kinetics. Taken together, our studies revealed three unexpected findings which require further analysis: (1) expression of Id2 mRNA is often associated with lymphocytic transformation by HTLV-I or -II; (2) T-cells usually express either Id2 or Id3 mRNA, but B-cells often express both simultaneously; (3) non-dividing, normal PBL express high levels of Id2 and no Id3 mRNA; and with the onset of cellular proliferation, levels of Id2 mRNA decrease while levels of Id3 mRNA increase, suggesting that regulation of expression of these closely related genes is disparate.


Blood | 1997

A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation

Roberta Morosetti; Dorothy J. Park; Chumakov Am; Grillier I; Masaaki Shiohara; Adrian F. Gombart; Tsuyoshi Nakamaki; Weinberg K; Koeffler Hp


Biochemical and Biophysical Research Communications | 1997

Vitamin D Receptor: No Evidence for Allele-Specific mRNA Stability in Cells Which Are Heterozygous for the Taq I Restriction Enzyme Polymorphism

Walter Verbeek; Adrian F. Gombart; Masaaki Shiohara; Moray J. Campbell; H. Phillip Koeffler


Blood | 1996

Id2 expression increases with differentiation of human myeloid cells.

Akira Ishiguro; Konstantin Spirin; Masaaki Shiohara; Andreas Tobler; A F Gombart; M A Israel; John D. Norton; H P Koeffler


Blood | 1999

Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.

Masaaki Shiohara; Marcia I. Dawson; Hobbs Pd; Nobukuni Sawai; Tsukasa Higuchi; Kenichi Koike; Atsushi Komiyama; Koeffler Hp


Archive | 2013

having juvenile myelomonocytic leukemia with specific RAS mutations Spontaneous improvement of hematologic abnormalities in patients

Yozo Nakazawa; Masaaki Shiohara; Atsushi Manabe; Seiji Kojima; Kenichi Koike; Yoshitoshi Ohtsuka; Eiko Hidaka; Kazuyoshi Yamauchi; Miyuki Tanaka; Ryu Yanagisawa; Susumu Iizuka; Kazutoshi Koike; Fumio Yanai; Keiichiro Kawasaki; Masakatsu Yanagimachi; Kazuyuki Matsuda; Akira Shimada; Nao Yoshida; Atsushi Ogawa; Akihiro Watanabe; Shuhei Yajima


Archive | 2010

CCAAT/enhancer binding protein-{epsilon} frameshift mutation in the gene encoding transcription factor Neutrophil-specific granule deficiency: homozygous recessive inheritance of a

Adrian F. Gombart; Masaaki Shiohara; Scott H. Kwok; Kazunaga Agematsu; Atsushi Komiyama; H. Phillip


Archive | 2010

Proliferation and Differentiation In Vitro Effects of Novel RAR- and RXR-Selective Retinoids on Myeloid Leukemic

Atsushi Komiyama; H. Phillip Koeffler; Masaaki Shiohara; Marcia I. Dawson; Peter D. Hobbs; Naoki Sawai; Tsukasa Higuchi; Kenichi Koike


Archive | 2010

mutations RAS having juvenile myelomonocytic leukemia with specific Spontaneous improvement of hematologic abnormalities in patients

Yozo Nakazawa; Masaaki Shiohara; Atsushi Manabe; Seiji Kojima; Kenichi Koike; Yoshitoshi Ohtsuka; Eiko Hidaka; Kazuyoshi Yamauchi; Miyuki Tanaka; Ryu Yanagisawa; Susumu Iizuka; Kazutoshi Koike; Fumio Yanai; Keiichiro Kawasaki; Masakatsu Yanagimachi; Kazuyuki Matsuda; Akira Shimada; Nao Yoshida; Atsushi Ogawa; Akihiro Watanabe; Shuhei Yajima

Collaboration


Dive into the Masaaki Shiohara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H. Phillip Koeffler

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dorothy J. Park

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Eiko Hidaka

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Kazutoshi Koike

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Konstantin Spirin

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Roberta Morosetti

Cedars-Sinai Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge